
Biomednewsbreaks - Kairos Pharma Ltd. (NYSE American: KAPA) Completes Safety Lead-In For Phase 2 Prostate Cancer Trial
(MENAFN- Investor Brand Network) Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharmaceutical company, announced completion of the safety lead-in for its Phase 2 trial evaluating ENV105 in combination with apalutamide for metastatic, castration …